Ajax Therapeutics Inc.
New York, US · Founded 2019 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
MV
Martin VogelbaumExecutive Officer, Director
RL
Ross LevineDirector
RF
Ramy FaridDirector
SP
Scott PlatshonDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$95MraisedMay 2024 · 21 investors · BiotechnologyRule 506(b)
▶$95MraisedMay 2024 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin VogelbaumExecutive Officer, Director
- Ross LevineDirector
- Scott PlatshonDirector
- Ramy FaridDirector
- Offering amount
- $95M
- Amount sold
- $95M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$37.4MraisedJun 2021 · 14 investors · BiotechnologyRule 506(b)
▶$37.4MraisedJun 2021 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin VogelbaumExecutive Officer, Director
- Ross LevineDirector
- Ramy FaridDirector
- Scott PlatshonDirector
- Offering amount
- $40M
- Amount sold
- $37.4M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$8MraisedJun 2019 · 6 investors · OtherRule 506(b)
▶$8MraisedJun 2019 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Martin VogelbaumExecutive Officer, Director
- Ross LevineDirector
- Ramy FaridDirector
- David SchnellDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.